AMD Busineess Development reviews

It became a challenge to raise funds to get through FDA med device approval process.

Continued annual restructuring and downsizing has left people over worked and underpaid, burnt out. Lack of competitive products and roadmap due to poor decision making is costing the company valuable partnerships and brand equity. Engineering is overworked and stretched to thin on too many projects, only exacerbating the situation.